Business Context and Reporting Period
This Form 8-K Current Report was filed by Novavax, Inc. on April 24, 2014. The report discloses a change in the Company's independent registered public accounting firm for the fiscal year ending December 31, 2014.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly procedural regarding the appointment of an auditor.
Material Changes
- Appointment of New Auditor: The Audit Committee selected Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2014, subject to standard client acceptance procedures.
- Dismissal of Prior Auditor: Grant Thornton LLP was notified of its dismissal as the Company's auditor upon completion of the work for the interim period ending March 31, 2014.
- Audit History: Grant Thornton's reports for fiscal years 2013 and 2012 contained no adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles.
- Disagreements: There were no disagreements or reportable events between the Company and Grant Thornton during the fiscal years ended December 31, 2013 and 2012, or the interim period through April 30, 2014.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary on business operations. It notes that the Company previously consulted Ernst & Young in 2013 regarding the accounting treatment of the acquisition of Isconova AB, but these activities were completed and reviewed by Grant Thornton in the 2013 audit. No other consultations with Ernst & Young regarding accounting principles or audit opinions occurred during the relevant periods.
Investor Verification Checklist
- Verify the receipt of the letter from Grant Thornton LLP (Exhibit 16.1) confirming their agreement with the statements regarding the dismissal and lack of disagreements.
- Confirm the completion of Ernst & Young's standard client acceptance procedures to finalize their appointment.
- Review the upcoming Form 10-Q for the period ending March 31, 2014, to see the final financial statements audited by Grant Thornton.